MASLD Clinical Study

Eli Lilly N1T-MC-MALO Study

Have you been diagnosed with MASLD and are at increased risk for developing major adverse liver outcomes? If so, you may be eligible to participate in a clinical research study evaluating investigational medications for the treatment of high-risk MASLD. We are looking for adults aged 18 to 75 to take part in this study.

There is no cost to participate. The study medication and all study-related tests that are not part of your usual medical care will be provided at no charge. You may also be reimbursed for study-related expenses.

To see if this study is right for you, please contact us.

Location: MNGI Digestive Health, Northeast Minneapolis Clinic
Physician Investigator: Dr. Ibrahim Hanouneh
Study Coordinator: Rudy Qamhiyeh

ATTENTION: This form is for information only and does not guarantee participation in any study. This form is also not meant for transmitting medical, prescription or appointment information or to initiate direct communications with our health care providers. Those inquiries should be sent through the Patient Portal or you can contact us at (612) 871-1145. Web form submissions are monitored Monday through Friday during regular business hours. In the event of a medical emergency, please dial 911.

CAPTCHA
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.